Oracle - The Transformation to Value-Based, Personalized Healthcare

You are cordially invited to attend a seminar.

Healthcare providers traditionally diagnose illness and prescribe medicines in a reactive fashion. While reactive medicine has certainly served us well to date, it has reached critical limits of sustainability as evidenced in the cost, quality, and patient satisfaction challenges the healthcare industry is currently facing. However, advances in science and technology are beginning to open the "black box" of biologic knowledge and are enabling the transformation of reactive medicine to a predictive, preventive, personalized and participatory state - P4 medicine.

Join Oracle thought leaders in the field of translational research and clinical analytics, and learn how leading healthcare and Academic Medical Centers:

Leverage new data platforms to integrate, store and analyze clinical and molecular data
Reduce costs
Increase the effectiveness and quality of patient care

Dr. Fred Lee
Director, Clinical and Translational
Informatics, HSGBU

Bill Heil
Healthcare Sales Executive
HSGBU

John McLaughlin
Consulting Sales Director
HSGBU

Deven Atnoor
Ph.D.,Principal Sales Consultant
HSGBU

Agenda
8:30 a.m. - 9:00 a.m.	Registration and Continental Breakfast
9:00 a.m. - 9:30 a.m.	Oracle's Clinical and Translational Medicine Strategies Bill Heil, Healthcare Sales Executive, Oracle Health Sciences
9:30 a.m. - 10:30 a.m.	Clinical and Genomic Data at the Bedside, A Physician's Perspective Dr. Fred Lee, Director, Clinical and Translational Informatics, Oracle Health Sciences
10:30 a.m. - 10:45 a.m.	Break
10:45 a.m. - 11:15 a.m.	Integrating Phenotypic and Genotypic Data – Lessons Learned John McLaughlin, Consulting Sales Director, Oracle Health Sciences
11:15 a.m. - 12:15 p.m.	One View of an Integrated Data Management System for Personalized Medicine Deven Atnoor, Ph.D., Principal Sales Consultant, Oracle Health Sciences
12:15 p.m.	Lunch and Interactive Demonstrations